Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.32% rose 1.52% to $169.31 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.72% falling 1.29% to 4,228.48 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.62% falling 0.86% to 33,706.74. Johnson & Johnson closed $17.38 below its 52-week high ($186.69), which the company reached on April 25th.
The stock outperformed some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +3.17% rose 0.87% to $337.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.83% rose 0.74% to $92.08, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.10% rose 1.17% to $49.15. Trading volume (8.1 M) eclipsed its 50-day average volume of 6.9 M.